Side-by-side financials for ABOS and ARGX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ABOS | ARGX |
|---|---|---|
| Market cap | - | $55.63 B |
| US-listed rank | - | #303 |
| Net income (latest FY) | -$121.33M | - |
| SEC filings | 336 | 272 |
Full pages: Acumen Pharmaceuticals, Inc. and ARGENX SE, or browse the full rankings.